FREE COMMUNICATION 18


11:45-13:15   HALL K


Free Communication Session 18 + Mini Lecture

CKD progression

Chairs: Gunnar Heine, Homburg/Saar, Germany
             Olivera Stojceva-Taneva, Skopje, F.Y.R. of Macedonia

Mini lecture
Interventions to reduce progression of CKD - what is the evidence?
John Feehally, Leicester, United Kingdom

FREE COMMUNICATIONS

MO024
URINARY PEPTIDE BIOMARKERS ASSOCIATED WITH IMPROVEMENT IN eGFR IN CKD PATIENTS
Katerina Markoska1, Martin Pejchinovski2, Claudia Pontillo2, Petra Zürbig2, Mohammed Dakna2, Jelka Masin-Spasovska1, Olivera Stojceva-Taneva1, Harald Mischak2, Goce Spasovski1, 1Fac Medicine, Dept Nephrology, Skopje, F.Y.R. of MACEDONIA, 2Mosaiques Diagnostics, GmbH, Hannover, GERMANY.

MO025
NON-INVASIVE MOLECULAR IMAGING OF KIDNEY FIBROSIS
Josef Ehling1,2, Barbara M. Klinkhammer1, Qinxue Sun1, Maike Baues1, Fabian Kiessling2, Jürgen Floege3, Twan Lammers2, Peter Boor1, 1RWTH Aachen Univ, Inst Pathology, Aachen, GERMANY, 2RWTH Aachen Univ, Dept Experimental Molecular Imaging, Aachen, GERMANY, 3RWTH Aachen Univ, Dept Nephrology, Aachen, GERMANY.

MO026
A URINARY PROTEOME-BASED CLASSIFIER FOR THE EARLY DETECTION OF DECLINE IN GLOMERULAR
FILTRATION
Claudia Pontillo1,2, Joost P. Schanstra3,4, Lotte Jacobs5, Yu-Mei Gu5, Zhenyu Zhang5, Mohammed
Dakna6, Petra Zürbig6, Justyna Siwy6, Jan A. Staessen5,7, Harald Mischak6,8, 1Mosaiques Diagnostics, R&D, Hannover, GERMANY, 2Charite-Universitatsmedizin, R&d, Berlin, GERMANY, 3Inserm, Metabolic and Cardiovascular Diseases, Toulouse, FRANCE, 4Univ Toulouse III Paul-Sabatier, R&d, Toulouse, FRANCE, 5Univ Leuven, Dept Cardiovascular Sciences, Leuven, BELGIUM, 6Mosaiques Diagnostics GmbH, R&D, Hannover, GERMANY, 7R&D VitaK Group, Maastricht Univ, R&d, Maastricht, NETHERLANDS, 8Univ Glasgow, Inst Cardiovascular and Medical Sciences, Glasgow, UK.

MO027
URINARY UROMODULIN AND COLLAGEN IV COMPLEX REFLECTS THE SEVERITY OF RENAL
IMPAIRMENT IN CHRONIC GLOMERULONEPHRITIS PATIENTS
Mikhail Shvetsov1,2, Zheng Antai2, Lidia Kozlovskaya3,2, Anna Serova4, Nikolay Mukhin3,2, 1I.M.
Sechenov First Moscow State Medical Univ, Dept and Chair Nephrology, Moscow, RUSSIAN FEDERATION, 2M.V. Lomonosov Moscow State Univ, Fac Fundamental Medicine, Moscow, RUSSIAN FEDERATION, 3I.M. Sechenov First Moscow State Medical Univ, Dept Internal Medicine and Occupational Diseases, Moscow, RUSSIAN FEDERATION, 4I.M. Sechenov First Moscow State Medical Univ, Dept Immunology, Moscow, RUSSIAN FEDERATION.

MO028
PROGRESSIVE IGA NEPHPHROPATHY AND DEFECTIVE COMPLEMENT INHIBITOR CD46 MRNA
EXPRESSION
Rosanna Coppo1, Licia Peruzzi2, Elisa Loiacono2, Massimiliano Bergallo3, Maria Luisa Russo4, Alessandro Amore2, Sigrid Lundberg5, Dita Maixnerova6, Vladimir Tesar6, Agnieszka Perkowska-PtasiŃska7, Dimitris Goumenos8, Miltiadis Gerolymos8, Kresimir Galesic9, Luka Toric9, Aikaterini Papagianni10, Maria Stangou10, Malgorzata Mizerska-Wasiak11, Loreto Gesualdo12, Eustacchio Montemurno12, Luisa Benozzi13, Stefano Cusinato13, Tomasz Hryszko14, Magdalena Krajewska15, Alexandra Krutova16, for VALIGA Immunonephrology WG ERA-EDTA, 1VALIGA, ERA-EDTA, Immunonephrology WG, ITALY, 2R Margherita H, Nephrol Dial Transpl, Turin, ITALY, 3Univ, Pediatrics, Turin, ITALY, 4VALIGA, ITALY, 5Karolinska Univ, Nephrol, Stockholm, SWEDEN, 6Gen Univ Hosp, Nephrol, Prague, CZECH REPUBLIC, 7Warsaw Univ, Transpl Med and Nephrol, Warsaw, POLAND, 8Univ H, Nephrol, Patras, GREECE, 9Univ H Dubrava, Nephrol, Zagreb, CROATIA, 10Aristotele Univ, Nephrol,
Thessaloniki, GREECE, 11Univ Hosp, Pediatrics, Warsaw, POLAND, 12Univ Bari, Nephrol Emerg and
Transplant, Bari, ITALY, 13Borgomanero H, Nephrol, No, ITALY, 14Univ Bialystok, Nephrol Transpl,
Bialystok, POLAND, 15Univ Wroclaw, Nephrol Transplant, Wroclaw, POLAND, 16Univ H, Vladivostock,
RUSSIAN FEDERATION.

 

back to the timetable

final programme "day by day" - may 21 - 24, 2016

today